Aytu BioScience Inc. (AYTU)

[DD2Gain]

You have quoted yourself, not the CEO.

You quoted the company as saying, "Virtually all antibody test-kits IN THE COMPANY"S WAREHOUSE (1.4 million tests, as of June 1, 2020) and those tests, that have been sold to date, have been sourced from Zhejiang Orient Gene."


What the company actually said was, "Virtually all antibody test kits in the Company’s warehouse and those tests that have been sold to date have been sourced from Orient Gene."

We have no idea how many authorized test kits were made available and sold relative to what was ordered and received from Biolitics

You are doing exactly what less-than-full-disclosure announcements rely upon from non-critical investors and promoters: to read more into a statement than what is actually said.

There isn't a single link you provided in which the company has stated that the 1.4 million kits REFERENCED IN EARLY JUNE were authorized through the EUA and NOT from Biolitics. How hard would it be for the CEO to state exactly what you have claimed he said considering the soured deal with Biolitics? The fact that he hasn't after a week is exactly why the market is showing a lack of faith in the stock at the moment. He is treating the company like a penny stock, not a Russel 3000 stock and it is very concerning.